Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
2(33%)
Results Posted
50%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_1
3
50%
Ph phase_3
3
50%

Phase Distribution

3

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 3Large-scale testing
3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(2)
Terminated(1)

Detailed Status

Recruiting2
Completed2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (50.0%)
Phase 33 (50.0%)

Trials by Status

recruiting233%
not_yet_recruiting117%
terminated117%
completed233%

Recent Activity

2 active trials
Showing 5 of 6
completedphase_1

Bioequivalence Study of Two Products of Apixaban 5mg Tablets in Healthy, Adult, Human Subjects

NCT06043297
recruitingphase_3

Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis

NCT06531122
recruitingphase_3

Dabigatran Versus Apixaban in Cerebral Venous Thrombosis

NCT06551415
not_yet_recruitingphase_1

Bioequivalence Study of Apixaban 5 mg Film-coated Tablets in Healthy Thai Volunteers

NCT06388239
completedphase_1

PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers

NCT05723510
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06043297Phase 1

Bioequivalence Study of Two Products of Apixaban 5mg Tablets in Healthy, Adult, Human Subjects

Completed
NCT06531122Phase 3

Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis

Recruiting
NCT06551415Phase 3

Dabigatran Versus Apixaban in Cerebral Venous Thrombosis

Recruiting
NCT06388239Phase 1

Bioequivalence Study of Apixaban 5 mg Film-coated Tablets in Healthy Thai Volunteers

Not Yet Recruiting
NCT05723510Phase 1

PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers

Completed
NCT04498273Phase 3

COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

Terminated

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6